CXCR1/2 inhibition enhances pancreatic islet survival after transplantation. [electronic resource]
Producer: 20130201Description: 3647-51 p. digitalISSN:- 1558-8238
- Adult
- Animals
- Blood Glucose -- analysis
- Cell Survival -- drug effects
- Chemokine CXCL1 -- biosynthesis
- Diabetes Mellitus, Experimental -- blood
- Diabetes Mellitus, Type 1 -- immunology
- Drug Evaluation, Preclinical
- Female
- Graft Rejection -- prevention & control
- Graft Survival -- drug effects
- Humans
- Interleukin-8 -- physiology
- Islets of Langerhans -- immunology
- Islets of Langerhans Transplantation -- immunology
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Middle Aged
- Natural Killer T-Cells -- immunology
- Neutrophils -- immunology
- Pilot Projects
- Receptors, Interleukin-8A -- antagonists & inhibitors
- Receptors, Interleukin-8B -- antagonists & inhibitors
- Sulfonamides -- pharmacology
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.